Bioteque Statistics

Total Valuation

Bioteque has a market cap or net worth of TWD 8.14 billion. The enterprise value is 7.29 billion.

Market Cap	8.14B
Enterprise Value	7.29B

Important Dates

The next estimated earnings date is Friday, May 9, 2025.

Earnings Date	May 9, 2025
Ex-Dividend Date	Jul 30, 2024

Share Statistics

Bioteque has 69.30 million shares outstanding. The number of shares has increased by 0.01% in one year.

Current Share Class	n/a
Shares Outstanding	69.30M
Shares Change (YoY)	+0.01%
Shares Change (QoQ)	+0.50%
Owned by Insiders (%)	3.84%
Owned by Institutions (%)	9.00%
Float	58.26M

Valuation Ratios

The trailing PE ratio is 15.48 and the forward PE ratio is 15.14.

PE Ratio	15.48
Forward PE	15.14
PS Ratio	3.93
PB Ratio	2.37
P/TBV Ratio	2.37
P/FCF Ratio	13.47
P/OCF Ratio	11.59
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.04, with an EV/FCF ratio of 12.05.

EV / Earnings	13.79
EV / Sales	3.52
EV / EBITDA	9.04
EV / EBIT	11.33
EV / FCF	12.05

Financial Position

The company has a current ratio of 3.92, with a Debt / Equity ratio of 0.22.

Current Ratio	3.92
Quick Ratio	3.30
Debt / Equity	0.22
Debt / EBITDA	0.92
Debt / FCF	1.23
Interest Coverage	68.63

Financial Efficiency

Return on equity (ROE) is 15.93% and return on invested capital (ROIC) is 9.73%.

Return on Equity (ROE)	15.93%
Return on Assets (ROA)	8.68%
Return on Invested Capital (ROIC)	9.73%
Return on Capital Employed (ROCE)	15.76%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.45
Inventory Turnover	3.79

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -6.75% in the last 52 weeks. The beta is 0.33, so Bioteque's price volatility has been lower than the market average.

Beta (5Y)	0.33
52-Week Price Change	-6.75%
50-Day Moving Average	123.57
200-Day Moving Average	126.99
Relative Strength Index (RSI)	47.65
Average Volume (20 Days)	146,462

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Bioteque had revenue of TWD 2.07 billion and earned 528.26 million in profits. Earnings per share was 7.59.

Revenue	2.07B
Gross Profit	905.08M
Operating Income	643.17M
Pretax Income	678.37M
Net Income	528.26M
EBITDA	791.52M
EBIT	643.17M
Earnings Per Share (EPS)	7.59

Full Income Statement

Balance Sheet

The company has 1.60 billion in cash and 740.63 million in debt, giving a net cash position of 855.82 million or 12.35 per share.

Cash & Cash Equivalents	1.60B
Total Debt	740.63M
Net Cash	855.82M
Net Cash Per Share	12.35
Equity (Book Value)	3.44B
Book Value Per Share	49.65
Working Capital	1.65B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 702.62 million and capital expenditures -98.13 million, giving a free cash flow of 604.49 million.

Operating Cash Flow	702.62M
Capital Expenditures	-98.13M
Free Cash Flow	604.49M
FCF Per Share	8.72

Full Cash Flow Statement

Margins

Gross margin is 43.67%, with operating and profit margins of 31.03% and 25.49%.

Gross Margin	43.67%
Operating Margin	31.03%
Pretax Margin	32.73%
Profit Margin	25.49%
EBITDA Margin	38.19%
EBIT Margin	31.03%
FCF Margin	29.17%

Dividends & Yields

This stock pays an annual dividend of 5.00, which amounts to a dividend yield of 4.27%.

Dividend Per Share	5.00
Dividend Yield	4.27%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	59.03%
Buyback Yield	-0.01%
Shareholder Yield	4.26%
Earnings Yield	6.49%
FCF Yield	7.42%

Dividend Details

Stock Splits

The last stock split was on August 20, 2015. It was a reverse split with a ratio of 0.8006917977.

Last Split Date	Aug 20, 2015
Split Type	Reverse
Split Ratio	0.8006917977

Scores

Bioteque has an Altman Z-Score of 6.38.

Altman Z-Score	6.38
Piotroski F-Score	n/a